Evidence-Based Oncology; Christopher B Williams, Paul Cornes; 2015

Evidence-Based Oncology Upplaga 1

av Christopher B Williams, Paul Cornes
Evidence-based Oncology was published at ASCO in May 2003 and immediately made a big impact on the world of clinical oncology. Belonging to the BMJ Books series of evidence-based textbooks, this internationally authored text provides guidance to clinical oncologists on the best evidence for screening and treatment of the major malignancies. With authoritative reviews based on Cochrane and other systematic reviews and high quality trials, the recommendations in this book provide unique information for treatment options in the context of the individual patient’s needs.

Need for a second edition

In the field of evidence-based medicine more than any, the need for fully up to date evidence is paramount. The recommendations in this book have remained current over the past three years, but clinical oncology has moved on, and a wider issues have come to the fore which need addressing. Rather than rely on short update commentaries on the website, the editors have decided they need to produce an entirely new edition in which the wider management issues of diagnosis, patient choice, health policy and health economics are covered. The new edition also provides an opportunity to add more chapters on conditions where sufficient evidence has emerged for treatment recommendations to be made.

Hence this second edition will be a different, richer and more comprehensive book than the first, and more in keeping with health care policy for the 21st century.

Features of the 2nd edition

30 additional new chapters
New section on care of the elderly
New section on palliative care
New section on delivery of care
More emphasis on diagnosis and screening
More emphasis on developing country issues
Relevant for health care providers and managed care as well as clinicians
Attractive new layout and cover design
Electronic delivery – either via CDRom or the Web
Evidence-based Oncology was published at ASCO in May 2003 and immediately made a big impact on the world of clinical oncology. Belonging to the BMJ Books series of evidence-based textbooks, this internationally authored text provides guidance to clinical oncologists on the best evidence for screening and treatment of the major malignancies. With authoritative reviews based on Cochrane and other systematic reviews and high quality trials, the recommendations in this book provide unique information for treatment options in the context of the individual patient’s needs.

Need for a second edition

In the field of evidence-based medicine more than any, the need for fully up to date evidence is paramount. The recommendations in this book have remained current over the past three years, but clinical oncology has moved on, and a wider issues have come to the fore which need addressing. Rather than rely on short update commentaries on the website, the editors have decided they need to produce an entirely new edition in which the wider management issues of diagnosis, patient choice, health policy and health economics are covered. The new edition also provides an opportunity to add more chapters on conditions where sufficient evidence has emerged for treatment recommendations to be made.

Hence this second edition will be a different, richer and more comprehensive book than the first, and more in keeping with health care policy for the 21st century.

Features of the 2nd edition

30 additional new chapters
New section on care of the elderly
New section on palliative care
New section on delivery of care
More emphasis on diagnosis and screening
More emphasis on developing country issues
Relevant for health care providers and managed care as well as clinicians
Attractive new layout and cover design
Electronic delivery – either via CDRom or the Web
Upplaga: 1a upplagan
Utgiven: 2015
ISBN: 9781405160032
Förlag: John Wiley & Sons
Format: Häftad
Språk: Engelska
Sidor: 760 st
Evidence-based Oncology was published at ASCO in May 2003 and immediately made a big impact on the world of clinical oncology. Belonging to the BMJ Books series of evidence-based textbooks, this internationally authored text provides guidance to clinical oncologists on the best evidence for screening and treatment of the major malignancies. With authoritative reviews based on Cochrane and other systematic reviews and high quality trials, the recommendations in this book provide unique information for treatment options in the context of the individual patient’s needs.

Need for a second edition

In the field of evidence-based medicine more than any, the need for fully up to date evidence is paramount. The recommendations in this book have remained current over the past three years, but clinical oncology has moved on, and a wider issues have come to the fore which need addressing. Rather than rely on short update commentaries on the website, the editors have decided they need to produce an entirely new edition in which the wider management issues of diagnosis, patient choice, health policy and health economics are covered. The new edition also provides an opportunity to add more chapters on conditions where sufficient evidence has emerged for treatment recommendations to be made.

Hence this second edition will be a different, richer and more comprehensive book than the first, and more in keeping with health care policy for the 21st century.

Features of the 2nd edition

30 additional new chapters
New section on care of the elderly
New section on palliative care
New section on delivery of care
More emphasis on diagnosis and screening
More emphasis on developing country issues
Relevant for health care providers and managed care as well as clinicians
Attractive new layout and cover design
Electronic delivery – either via CDRom or the Web
Evidence-based Oncology was published at ASCO in May 2003 and immediately made a big impact on the world of clinical oncology. Belonging to the BMJ Books series of evidence-based textbooks, this internationally authored text provides guidance to clinical oncologists on the best evidence for screening and treatment of the major malignancies. With authoritative reviews based on Cochrane and other systematic reviews and high quality trials, the recommendations in this book provide unique information for treatment options in the context of the individual patient’s needs.

Need for a second edition

In the field of evidence-based medicine more than any, the need for fully up to date evidence is paramount. The recommendations in this book have remained current over the past three years, but clinical oncology has moved on, and a wider issues have come to the fore which need addressing. Rather than rely on short update commentaries on the website, the editors have decided they need to produce an entirely new edition in which the wider management issues of diagnosis, patient choice, health policy and health economics are covered. The new edition also provides an opportunity to add more chapters on conditions where sufficient evidence has emerged for treatment recommendations to be made.

Hence this second edition will be a different, richer and more comprehensive book than the first, and more in keeping with health care policy for the 21st century.

Features of the 2nd edition

30 additional new chapters
New section on care of the elderly
New section on palliative care
New section on delivery of care
More emphasis on diagnosis and screening
More emphasis on developing country issues
Relevant for health care providers and managed care as well as clinicians
Attractive new layout and cover design
Electronic delivery – either via CDRom or the Web
Begagnad bok (0 st)
Begagnad bok (0 st)